drugset / Trial / NCT00218257

Progesterone for the Treatment of Cocaine Dependence - 1

NCT00218257

RandomizedCrossoverTriple-blindTreatment

Summary

Past research has demonstrated that cocaine dependent women experience less severe responses to cocaine during the luteal phase of the menstrual cycle, when estrogen and progesterone concentrations are high. The purpose of this study is to determine whether administered progesterone reduces subjective and physiological responses to cocaine in cocaine dependent individuals.

Timeline

Start
2002-07
Primary completion
2008-04
Completion
2008-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 200 mg

Indications